KalVista Pharmaceuticals
Alexander Cecil has extensive experience in the pharmaceutical industry, with a background in medicinal chemistry. Alexander has held various roles at both KalVista Pharmaceuticals, Inc. and Karus Therapeutics Limited, including Associate Director, CMC and Research Team Leader. Alexander has managed projects from development candidate nomination to successful clinical trial filings, working closely with internal and external teams. With over 10 years of experience in industrial medicinal chemistry, Alexander has expertise in GxP, project management, and laboratory operations. Alexander also has a strong academic background, holding a PhD in Organic Chemistry from the University of Southampton.
This person is not in any offices
KalVista Pharmaceuticals
2 followers
KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases....